FIELD: pharmaceutics.
SUBSTANCE: invention relates to the field of pharmaceutics, namely to the use of an aqueous composition for stimulating innate immunity in a subject in order to prevent diseases caused by pathogen agent invasion through the skin, eye or mucous membrane. The used aqueous composition includes filtered sweater and fucan of Ascophyllum nodosum, having molecular weight from 2 to 21 kDa in a certain ratio.
EFFECT: invention provides for the use of a composition having an immune-stimulating effect to increase secretion of beta-defensin-2, increase autophagic capability of cells, increase IL-10 secretion.
10 cl, 11 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EXTRACT FOR TREATMENT OF PERIODONTUM DISEASES | 2004 |
|
RU2275206C2 |
| METHOD FOR EVALUATING CONGENITAL IMMUNITY IN PATIENTS WITH RECURRENT EXUDATIVE OTITIS MEDIA | 2020 |
|
RU2739686C1 |
| BIFIDOBACTERIUM LONGUM, ABLE TO MODULATE THE IMMUNE RESPONSE TO A RESPIRATORY VIRAL INFECTION | 2018 |
|
RU2768030C2 |
| LACTOBACILLUS SALIVARIUS PROBIOTIC STRAIN (VARIANTS), PROBIOTIC PREPARATION BASED ON THE SAME, AND METHOD FOR TREATMENT OR PREVENTION USING LACTOBACILLUS SALIVARIUS STRAINS | 2002 |
|
RU2302458C2 |
| STRAIN OF LACTIC BACTERIUM FOR TREATING INFLAMMATION IN INFLAMMATORY INTESTINAL DISEASE, COMPONENT EFFECTIVE IN TREATING ULCER, METHOD OF TREATING INFLAMMATION IN INFLAMMATORY INTESTINAL DISEASE, PRODUCT (VERSIONS) AND COMPOSITION (VERSIONS) | 2006 |
|
RU2378370C2 |
| AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2734420C1 |
| BLOCKING OF INFLAMMATORY PROTEASES BY THETA-DEFENSINS | 2012 |
|
RU2652605C2 |
| ADJUVANT | 2020 |
|
RU2736933C1 |
| APPLICATION OF BACTERIAL GHOSTS FOR MEDIATED STIMULATION OF INNATE IMMUNITY | 2011 |
|
RU2564110C2 |
| METHODS OF TREATMENT WITH APPLICATION OF PURIFIED (DECOLOURIZED) DRY JUICE OF ALOE VERA LEAF | 2017 |
|
RU2738776C2 |
